Drug Approvals by USFDA in March 2015

Drug 

Date

Indication

Remark

Nivolumab March 4, 2015 Advanced (metastatic) squamous non-small cell lung cancer (NSCLC) Expanded use
Filgrastim biosimillar March 6, 2015 First biosimilar product approved to stimulate the proliferation and differentiation of granular First biosimilar
Isavuconazonium sulfate March 6, 2015 Invasive aspergillosis and invasive mucormycosis A new antifungal drug
Dinutuximab March 10, 2015 First-line therapy for pediatric patients with high-risk neuroblastoma With Boxed warning
Cholic acid March 17, 2015 Rare bile acid synthesis disorders  
Anthrax immune globulin intravenous March 25, 2015 Inhalational anthrax  In combination with appropriate antibiotic drug
Aflibercept March 25, 2015 Diabetic retinopathy in patients with diabetic macular edema. Expanded use